Back to Search Start Over

Genetic and environmental risk factors for oral anticoagulant overdose.

Authors :
Verstuyft C
Robert A
Morin S
Loriot MA
Flahault A
Beaune P
Funck-Brentano C
Jaillon P
Becquemont L
Source :
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2003 Mar; Vol. 58 (11), pp. 739-45. Date of Electronic Publication: 2003 Feb 18.
Publication Year :
2003

Abstract

Background: Cytochrome P450 2C9 (CYP2C9) allelic variant carriers have been shown to experience hyper-responsiveness to small doses of oral anticoagulants (OAs) (warfarin or acenocoumarol) and a higher bleeding rate.<br />Objectives: To determine the relative frequencies of different risk factors for OA overdose including diet, concomitant diseases, drug interactions, recent increment of OA dose and CYP2C9 genetic polymorphism among hospitalised patients.<br />Materials and Methods: Frequencies of the different risk factors for OA overdose were determined in a prospective case-control study. Seventy-five consecutive patients with an International normalised ratio (INR) greater than 4 were matched with seventy-five control patients with an INR greater than 2 but less than 3.5 with respect to age, prescribed OA and daily dose. Genotyping of CYP2C9*2 and CYP2C9*3 allelic variants was detected by the TaqMan allelic discrimination assay.<br />Results: Drug interactions and a recent increment of OA dose were the only significant independent risk factors identified in the first analysis with odds ratio 2.13 (95% CI: 1.06-4.28) and 3.38 (95%CI: 1.51-7.57), respectively. A recent increment of OA dose was the only significant independent risk factor identified among the patients treated with coumarin derivatives (acenocoumarol or warfarin), excluding those treated with fluindione; the odds ratio was 4.3 (95% CI: 1.5-12.3). CYP2C9 genetic polymorphism did not significantly predict the increased risk of OA overanticoagulation in this study. However three homozygous CYP2C9*3/CYP2C9*3 genotype patients were found among the cases, whereas no such patients could be identified among controls.<br />Conclusion: This is the first observational study investigating the role of CYP2C9 genetic polymorphism together with other environmental OA overdose risk factors. Our results support the view that although the CYP2C9*3/CYP2C9*3 genotype is associated soon after the introduction of OA with dramatic overanticoagulation, OA overdose is mostly related to environmental factors.

Details

Language :
English
ISSN :
0031-6970
Volume :
58
Issue :
11
Database :
MEDLINE
Journal :
European journal of clinical pharmacology
Publication Type :
Academic Journal
Accession number :
12634980
Full Text :
https://doi.org/10.1007/s00228-002-0538-2